Basilea Pharmaceutica Ltd. Logo
 

Products

 
 
 
  • Zevtera®/Mabelio® (ceftobiprole) is an intravenous antibiotic from the cephalosporin class.
    More information for healthcare professionals is available under the following link.

  • Cresemba® (isavuconazole) is an intravenous and oral antifungal from the azole class.
     

  • Toctino® (alitretinoin) is an oral product for the treatment of chronic hand eczema from the class of retinoids. Alitretinoin was developed and brought to market by Basilea. Basilea entered into a global agreement on alitretinoin with Stiefel, a GSK company, in June 2012. More information for healthcare professionals is available under the following link.

     

 
Info